ReMYND

Developing treatments for Alzheimer’s, diabetes and other diseases caused by cellular dysfunction.

HQ location

Leuven, Belgium

Website

Launch date

Feb 2002

Employees

Enterprise value

$53—79m

Company register number

Jobs

View job openings

https://twitter.com/remyndnv https://www.linkedin.com/company/remynd-nv/

Authorizing premium user...